Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Spero

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Human Vaccines & Immunotherapeutics|April 10, 2012
New vaccines needed for pathogens infecting animals and humans: One HealthAndres H Gutiérrez, Denice M Spero, Cyril Gay, et al.
The Journal of Pediatrics|July 1, 1971
The question of trisomy 22 syndromeR M Goodman, M B Katznelson, M Spero, et al.
European Journal of Pharmacology|April 25, 2006
An orally active reversible inhibitor of cathepsin S inhibits human trans vivo delayed-type hypersensitivitySudha N Desai, Della M White, Kathryn M O'shea, et al.
Journal of Medicinal Chemistry|April 1, 1994
Benzoxazolamines and benzothiazolamines: potent, enantioselective inhibitors of leukotriene biosynthesis with a novel mechanism of actionE S Lazer, C K Miao, H C Wong, et al.
Bioorganic & Medicinal Chemistry|January 23, 2003
The design of potent hydrazones and disulfides as cathepsin S inhibitorsCharles L Cywin, Raymond A Firestone, Daniel W McNeil, et al.
Bioorganic & Medicinal Chemistry Letters|March 24, 2007
Identification of a novel class of succinyl-nitrile-based Cathepsin S inhibitorsYounes Bekkali, David S Thomson, Raj Betageri, et al.
Journal of Medicinal Chemistry|December 3, 2002
Design and synthesis of dipeptide nitriles as reversible and potent Cathepsin S inhibitorsYancey D Ward, David S Thomson, Leah L Frye, et al.
Bioorganic & Medicinal Chemistry Letters|October 24, 2006
Discovery of potent and selective PKC-theta inhibitorsCharles L Cywin, Georg Dahmann, Anthony S Prokopowicz, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Human Vaccines & Immunotherapeutics|April 10, 2012
New vaccines needed for pathogens infecting animals and humans: One HealthAndres H Gutiérrez, Denice M Spero, Cyril Gay, et al.
The Journal of Pediatrics|July 1, 1971
The question of trisomy 22 syndromeR M Goodman, M B Katznelson, M Spero, et al.
European Journal of Pharmacology|April 25, 2006
An orally active reversible inhibitor of cathepsin S inhibits human trans vivo delayed-type hypersensitivitySudha N Desai, Della M White, Kathryn M O'shea, et al.
Journal of Medicinal Chemistry|April 1, 1994
Benzoxazolamines and benzothiazolamines: potent, enantioselective inhibitors of leukotriene biosynthesis with a novel mechanism of actionE S Lazer, C K Miao, H C Wong, et al.
Bioorganic & Medicinal Chemistry|January 23, 2003
The design of potent hydrazones and disulfides as cathepsin S inhibitorsCharles L Cywin, Raymond A Firestone, Daniel W McNeil, et al.
Bioorganic & Medicinal Chemistry Letters|March 24, 2007
Identification of a novel class of succinyl-nitrile-based Cathepsin S inhibitorsYounes Bekkali, David S Thomson, Raj Betageri, et al.
Journal of Medicinal Chemistry|December 3, 2002
Design and synthesis of dipeptide nitriles as reversible and potent Cathepsin S inhibitorsYancey D Ward, David S Thomson, Leah L Frye, et al.
Bioorganic & Medicinal Chemistry Letters|October 24, 2006
Discovery of potent and selective PKC-theta inhibitorsCharles L Cywin, Georg Dahmann, Anthony S Prokopowicz, et al.
Pageof 2